Skinvisible (SKVI) Price to Sales (2010 - 2026)

Skinvisible has disclosed Price to Sales across 17 years of filings, most recently posting 226.96 for Q2 2026.

• In Q2 2026, Price to Sales fell 22.22% year-over-year to 226.96; the TTM figure through Jun 2026 stood at 56.74 (down 22.22% YoY), while the FY2025 annual figure was 62.14, down 31.25% from the prior year.
• Price to Sales came in at 226.96 for Q2 2026 at Skinvisible, down from 259.38 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 733.48 in Q2 2024 to a low of 2.66 in Q2 2022.
• Average Price to Sales over 5 years is 224.82, with a median of 126.46 recorded in 2022.
• Year-over-year, Price to Sales slumped 76.26% in 2022 and jumped 3316.67% in 2023.
• Over 5 years, Price to Sales stood at 90.8 in 2022, then slipped by 20.0% to 72.64 in 2023, then soared by 397.74% to 361.55 in 2024, then slumped by 31.25% to 248.58 in 2025, then retreated by 8.7% to 226.96 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 226.96 in Q2 2026, 259.38 in Q1 2026, and 248.58 in Q4 2025.